Potentiators and Inhibitors of Insulin Secretion

Advances in Molecular and Cell Biology

Volumn 29, Issue C, 1999, Pages 175-197

  Ahrén, Bo ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77955615245     PISSN: 15692558     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1569-2558(08)60093-4     Document Type: Article

References (79)

1. Af Klinteberg K., Karlsson S., and Ahrén B. Signaling mechanisms underlying the insulino-tyropic effect of pituitary adenylate cycliase-activating polypeptide in HIT-T15 cells. Endocrinology 137 (1996) 2791-2798
2. Ahrén B. Effects of galanin and calcitonin gene-related peptide on insulin and glucagon secretion in man. Acta Endocrinol. 123 (1990) 591-597
3. Ahrén B. In: Jensen S.L., Gregersen H., Moody F., and Shokouh-Amiri M.H. (Eds). Essentials of Experimental Surgery: Gastroenterology and Endocrinology (1996), Har-wood Academic, London 1-18
4. Ahrén B. In: Jensen S.L., Gregersen H., Moody F., and Shokouh-Amiri M.H. (Eds). Essentials of Experimental Surgery: Gastroenterology and Endocrinology (1996), Har-wood Academic, London 1-24
5. Ahrén B., Ar'Rajab A., Böttcher G., Sundler F., and Dunning B.E. Presence of galanin in human pancreatic nerves and inhibition of insulin secretion from isolated human islets. Cell Tissue Res. 264 (1991) 263-267
6. Ahrén B., Bertrand G., Roye M., and Ribes G. Pancreastatin modulates glucose-stimulated insulin secretion from the perfused rat pancreas. Acta Physiol. Scand. 158 (1996) 63-70
7. Ahrén B., and Karlsson S. In: Flatt R., and Lenzen S. (Eds). Insulin Secretion and Pancreatic β-cell Research (1994), Smith-Gordon, London 313-318
8. Ahrén B., Karlsson S., and Lindskog S. In: Aquilonius S., and Gillberg P.G. (Eds). Progress in Brain Research, vol. 84: Cholinergic Neurotransmission (1990), Elsevier, Amsterdam 209-218
9. Ahrén B., Larsson H., and Hoist J.J. Effects of glucagon-like peptide-1 on islet function and insulin sensitivity in noninsulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 82 (1997) 473-478
10. Ahrén B., and Lindskog S. Galanin and the regulation of islet hormone secretion. Int. J. Pan-creatol. 11 (1992) 147-160
11. Ahrén B., Lindskog S., Tatemoto K., and Efendic S. Pancreastatin inhibits insulin secretion and stimulates glucagon secretion in mice. Diabetes 37 (1988) 281-285
12. Ahrén B., Nobin A., and Scherstén B. Insulin and C-peptide secretory responses to glucagon in man: Studies on the dose-response relationships. Acta Med. Scand. 221 (1987) 185-190
13. Ahrén B., Ostenson C.G., Mårtensson H., and Efendic S. Pancreatic release of pancreastatin in the pig. Pancreas 6 (1991) 324-329
14. Ahrén B., and Pettersson M. Calcitonin gene-related peptide (CGRP) and amylin and the endocrine pancreas. Int. J. Pancreatol. 6 (1990) 1-15
15. (736)amide and cytoplasmic calcium in insulin producing cells. Acta Physiol. Scand. 157 (1996) 333-341
16. Ahrén B., and Taborsky Jr. G.J. The mechanism of vagal nerve stimulation of glucagon and insulin secretion in the dog. Endocrinology 118 (1986) 1551-1557
17. Ahrén B., Taborsky Jr. G.J., and Porte Jr. D. Neuropeptidergic versus cholinergic and adrenergic regulation of islet hormone secretion. Diabetologia 28 (1986) 827-836
18. Ahrén B., Veith R.C., and Taborsky Jr. G.J. The effects of epinephrine on islet hormone secretion in the dog. Int. J. Pancretol. 3 (1988) 375-388
19. Ar'Rajab A., and Ahrén B. Effects of amidated rat islet amyloid polypeptide on glucose-stimulated insulin secretion in vivo and in vitro in rats. Eur. J. Pharmacol. 192 (1991) 443-445
20. Bonner-Weir S. In: Samoles E. (Ed). The Endocrine Pancreas (1991), Raven Press, New York 15-27 E21-E27
21. Böttcher G., Ahrén B., Lundquist I., and Sundler F. Peptide YY: Intrapancreatic localization and effects on insulin and glucagon secretion in the mouse. Pancreas 4 (1989) 282-288
22. Boyle P.J., Shah S.D., and Cryer P.E. Insulin, glucagon, and catecholamines in prevention of hypoglycemia during fasting. Am. J. Physiol. 256 (1989) E651-E661
23. Byrne M.M., Sturis J., and Polonsky K.S. Insulin secretion and clearance during low-dose graded glucose infusion. Am. J. Physiol. 268 (1995) E21-E27
24. Clark A. Islet amyloid: An enigma of type 2 diabetes. Diabetes/Metabol. Rev. 8 (1992) 117-132
25. Cooper G.J.S. Amylin compared with calcitonin gene-related peptide: structure, biology, and relevance to metabolic disease. Endocr. Rev. 15 (1994) 163-201
26. Creutzfeldt W. The incretin concept today. Diabetologia 16 (1979) 75-85
27. Dunning B.E., Karlsson S., and Ahrén B. Contribution of galanin to stress-induced impairment of insulin secretion in swimming mice. Acta Physiol. Scand. 143 (1991) 145-152
28. Dunning B.E., and Taborsky Jr. G.J. Galanin-sympathetic neurotransmitter in endocrine pancreas?. Diabetes 37 (1988) 1157-1162
29. Fehmann H.C., Göke R., and Göke B. Cell and molecular biology of the incretin hormones glucagon-like peptide-1 and glucose-dependent insulin releasing polypeptide. Endocr. Rev. 16 (1995) 390-410
30. Galbo H., Richter E.A., Christensen N.J., and Hoist J.J. Sympathetic control of metabolic and hormonal responses to exercise in rats. Acta Physiol. Scand. 102 (1978) 441-449
31. Gebre-Medhin S., Mulder H., Pekny M., Zhang Y.Z., Törnell J., Westermark P., Sundler R., Ahrén B., and Betsholtz C. Altered glucose homeostasis, body weight and nociception in IAPP (amylin) null mutant mice. Diabetes 46 Suppl. 1 (1997) 29A
32. 125I-glucagon and activation of adenylate cyclase. J. Biol. Chem. 247 (1972) 1211-1218
33. Gregersen S., and Ahrén B. Studies on the mechanisms by which gastrin releasing peptide stimulates insulin secretion from mouse islets. Pancreas 12 (1996) 48-57
34. Gremlich S., Porret A., Hani E.H., Cherif D., Vionnet N., Froguel P., and Thorens B. Cloning, functional expression, and chromosomal localization of the human pancreatic islet glucose-dependent insulinotropic polypeptide receptor. Diabetes 44 (1995) 1202-1208
35. Gutniak M.K., Larsson H., Heiber S.J., Juneskans O.T., Hoist J.J., and Ahrén B. Potential therapeutic levels of glucagon-like peptide-1 achieved in humans by a buccal tablet. Diabet Care 19 (1996) 843-848
36. Gutniak M., Ørskov C., Hoist J.J., Ahrén B., and Efendic S. Antidiabetogenic effect of glucagon-like peptide-1 (7-36) amide in normal subjects and patients with diabetes mellitus. N. Engl. J. Med. 326 (1992) 1316-1322
37. Hertelendy Z.I., Patel D.G., and Knittel J.J. Pancreastatin inhibits insulin secretion in RINm5F-cells through obstruction of G-protein mediated, calcium-directed exocytosis. Cell Calcium 19 (1996) 125-132
38. Hoist J.J., Grönholt R., Schaffalitzky de Muckadell O.B., and FAhrénkrug J. Nervous control of pancreatic endocrine secretion in pigs. II. The effect of pharmacological blockade on the response to vagal stimulation. Acta Physiol. Scand. 111 (1981) 9-14
39. Hoist J.J., Ørskov C., and Bersani M. In: Samols E. (Ed). The Endocrine Pancreas (1991), Raven Press, New York 125-152
40. Houwing H., Frankel K.M., Strubbe J.H., van Suylichem P.T., and Steffens A.B. Role of the sympathoadrenal system in exercise-induced inhibition of insulin secretion. Effects of islet transplantation. Diabetes 44 (1995) 565-571
41. Kahn S.E., D'Alessio J.W., Schwartz M.W., Fujimoto W.Y., Ensinck J.W., Taborsky Jr. G.J., and Porte Jr. D. Evidence of cosecretion of islet amyloid polypeptide by β-cells. Diabetes 39 (1990) 634-638
42. Karam J.H., Grodsky G.M., Ching K.N., Schmid E., Burrill K., and Forsham P.H. "Staircase" glucose stimulation of insulin secretion in obesity. Measure of beta-cell sensitivity and capacity. Diabetes 23 (1974) 673-770
43. Karlsson S., and Ahrén B. Cholecystokinin and the regulation of insulin secretion. Scand. J. Gastroenterol. 27 (1992) 161-165
44. Karlsson S., and Ahrén B. Muscarinic receptor subtypes in carbachol-stimulated insulin and glucagon secretion in the mouse. J. Autonom. Pharmacol. 13 (1993) 439-446
45. Karlsson S., and Ahrén B. Gastrin-releasing peptide mobilizes calcium from intracellular stores in HIT-T15 cells. Peptides 17 (1996) 909-916
46. Karlsson S., and Ahrén B. A role for islet peptide YY in the regulation of insulin secretion Acta. Physiol. Scand. 157 (1996) 305-306
47. Karlsson S., Fridolf T., and Ahrén B. In: Flatt P.R., and Lenzen S. (Eds). Insulin Secretion and Pancreatic β-cell Research (1994), Smith-Gordon, London 337-342
48. 2 and insulin secretion in pancreatic islets. Biochem. J. 287 (1992) 283-290
49. Kreyman B., Ghatei M.A., Williams G., and Bloom S.R. Glucagon like peptide-1(7-36): A physiological incretin in man. Lancet 2 (1987) 1300-1304
50. Lacey R.J., Cable H.C., James R.F., London N.J., Scarpello J.H., and Morgan N.G. Concentration-dependent effects of adrenaline on the profile of insulin secretion from isolated human islets. J. Endocrinol. 138 (1993) 555-563
51. Larsson L.I., Sundler F., and Håkanson R. Pancreatic polypeptide-a postulated new hormone: identification of its cellular storage site by light and electron immunocytochemistry. Diabetologia 12 (1976) 211-216
52. Leighton B., and Cooper G.J. Pancreatic amylin and calcitonin gene-related peptide cause resistane to insulin in skeletal muscle in vitro. Nature 335 (1988) 632-635
53. Lindskog S., Skoglund G., and Ahrén B. Pancreastatin inhibits insulin secretion from isolated rat islets: studies on its mechanism of action. Diabet. Res. 19 (1992) 119-123
54. Lorenzo A., Razzaboni B., Weir G.C., and Yankner B.A. Pancreatic islet cell toxicity of amylin asociated with type-2 diabetes mellitus. Nature 368 (1994) 756-760
55. Ma H.T., Kato M., and Tatemoto K. Effects of pancreastatin and somatostatin on secreta-gogue-induced rise in intracellular free calcium in single rat pancreatic islet cells. Regul. Pept. 61 (1996) 173-178
56. Maeda P. Gap junction involvement in secretion: the pancreas experience. Clin. Exp. Pharmacol. Physiol. 23 (1996) 1053-1057
57. Mulder H., Ahrén B., and Sundler F. Recent advances in localization and quantification of gene expression-A lesson from islet amyloid polypeptide. Cell Vision 2 (1995) 94-103
58. Nieuwenhuizen A.G., Karlsson S., Fridolf T., and Ahrén B. Mechanisms underlying the insulinostatic effect of peptide YY in mouse pancreatic islets. Diabetologia 37 (1994) 871-878
59. Östenson C.G., Ahrén B., Johansson O., Karlsson S., Hilliges M., and Efendic S. Diazepam binding inhibitor and the endocrine pancreas. Neuropharmacology 30 (1991) 1391-1398
60. Pettersson M., and Ahrén B. Calcitonin gene-related peptide inhibits insulin secretion. Studies on ion fluxes and cyclic AMP in isolated rat islets. Diabet. Res. 15 (1990) 9-14
61. Porte Jr. D. A receptor mechanism for the inhibition of insulin release by epinephrine in man. J. Clin. Invest. 46 (1967) 86-94
62. Porte Jr. D. β-Cells in type II diabetes mellitus. Diabetes 40 (1991) 166-180
63. 2+, cAMP and phospholipid-derived messengers in coupling mechanisms of insulin secretion. Physiol. Rev. 67 (1987) 1185-1248
64. + channel in mouse pancreatic β-cells. Nature 349 (1991) 77-79
65. Samols E., and Stagner J.I. In: Samols E. (Ed). The Endocrine Pancreas (1991), Raven Press, New York 93-124
66. Sanchez-Margalet V., Lucas M., and Goberna R. Pancreastatin: Further evidence for its consideration as a regulatory peptide. J. Molecul. Endocrinol. 16 (1996) 1-8
67. Sharp G.W.G. Mechanisms of inhibition of insulin release. Am. J. Physiol. 271 (1996) C1781-C1799
68. 2 and arachidonic acid in cholecystokinin-8-induced insulin secretion in rat islets. Regul. Pept. 65 (1996) 101-107
69. Skoglund G., Gross R., Ahrén B., and Loubatieres-Mariani M.M. Different mechanisms are involved in neuropeptide Y-induced pancreatic vasoconstriction and inhibition of insulin secretion. Eur. J. Pharmacol. 236 (1993) 69-74
70. Smith D.M., and Bloom S.R. Paracrine/autocrine control of the islet and the amylin family. Biochem. Soc. Trans. 23 (1995) 336-340
71. Straub S.G., and Sharp G.W.G. A wortmannin-sensitive signal transduction pathway is involved in the stimulation of insulin release by vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptide. J. Biol. Chem. 271 (1996) 1660-1668
72. Tatemoto K., Carlquist M., and Mutt V. Neuropeptide Y-a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 296 (1982) 659-660
73. Taylor S.H., and Majid P.A. Insulin and the heart. J. Mol. Cell. Cardiol. 2 (1971) 293-317
74. Teff K.L., and Engelman K. Oral sensory stimulation improves glucagon tolerance in humans: effects on insulin, C-peptide, and glucagon. Am. J. Physiol. 270 (1996) R1371-R1379
75. Verchere C.B., Kowalyk S., Koerker D.J., Baskin D.G., and Taborsky Jr. G.J. Evidence that galanin is a parasympathetic, rather than a sympathetic, neurotransmitter in the baboon pancreas. Regul. Pept. 67 (1996) 93-101
76. Wagoner P.K., Chen C., Woriey J.F., Dukes I.D., and Oxford G.S. Amylin modulates β-cell glucose sensing via effects on stimulus-secretion coupling. Proc. Natl. Acad. Sci. USA 90 (1993) 9145-9149
77. Westermark P., Johnson K.H., O'Brien T.D., and Betsholtz C. Islet amyloid polypeptide-a novel controversy in diabetes research. Diabetologia 35 (1992) 297-303
78. Wolf B.A., Konrad R.J., and Alter C.A. In: Flatt R.R., and Lenzen S. (Eds). Insulin Secretion and Pancreatic β-cell Research (1994), Smith-Gordon, London 297-304
79. Yada T., Sakurada M., Ihida K., Nakata M., Murata E., Arimura A., and Kikuchi M. Pituitary adenylate cyclase activating polypeptide is an extraordinarily potent intra-pancreatic regulator of insulin secretion from islet beta-cells. J. Biol. Chem. 269 (1994) 1290-1293